enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Treatment and management of COVID-19 - Wikipedia

    en.wikipedia.org/wiki/Treatment_and_management...

    Highly effective vaccines have reduced mortality related to SARS-CoV-2; however, for those awaiting vaccination, as well as for the estimated millions of immunocompromised persons who are unlikely to respond robustly to vaccination, treatment remains important. [4]

  3. SARS-CoV-2 - Wikipedia

    en.wikipedia.org/wiki/SARS-CoV-2

    On 11 February 2020, the International Committee on Taxonomy of Viruses adopted the official name "severe acute respiratory syndrome coronavirus 2" (SARS‑CoV‑2). [33] To avoid confusion with the disease SARS , the WHO sometimes refers to SARS‑CoV‑2 as "the COVID-19 virus" in public health communications [ 34 ] [ 35 ] and the name HCoV ...

  4. SARS - Wikipedia

    en.wikipedia.org/wiki/SARS

    Severe acute respiratory syndrome (SARS) is a viral respiratory disease of zoonotic origin caused by the virus SARS-CoV-1, the first identified strain of the SARS-related coronavirus. [3] The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak .

  5. The major COVID variants we've seen so far and which one to ...

    www.aol.com/news/major-covid-variants-weve-seen...

    According to the CDC, staying up to date with SARS-CoV-2 vaccination was considered the best way to prevent hospitalization and severe illness caused by EG.5 and BA.2.86.

  6. COVID-19 drug development - Wikipedia

    en.wikipedia.org/wiki/COVID-19_drug_development

    Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus 2, known as SARS-CoV-2. [107] [108] [109] It was developed by GlaxoSmithKline and Vir Biotechnology, Inc. [108] [110] Sotrovimab is designed to attach to the spike protein of SARS-CoV-2 ...

  7. Molnupiravir - Wikipedia

    en.wikipedia.org/wiki/Molnupiravir

    [43] [16] In December 2021, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for molnupiravir for the treatment of mild-to-moderate COVID‑19 in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progression to severe COVID‑19, including hospitalization or death, and ...

  8. COVID-19 drug repurposing research - Wikipedia

    en.wikipedia.org/wiki/COVID-19_drug_repurposing...

    Part of a series on the COVID-19 pandemic Scientifically accurate atomic model of the external structure of SARS-CoV-2. Each "ball" is an atom. COVID-19 (disease) SARS-CoV-2 (virus) Cases Deaths Timeline 2019 2020 January responses February responses March responses April responses May responses June responses July responses August responses September responses October responses November ...

  9. At Last, New Weapons in the Fight Against Colds and Flu

    www.aol.com/lifestyle/last-weapons-fight-against...

    Colds also result from coronaviruses (the Covid-causing SARS-CoV-2 isn’t the only one!), adenoviruses, respiratory syncytial viruses (RSV), and parainfluenza viruses.